General
Biotech giant to slash 3000 jobs, spin-off vaccine arm
Australian pharmaceutical giant CSL will cut as many as 3000 jobs and spin-off its flu vaccine arm into a separate business in a bid to shave $500 million from its bottom line.
The…
Continue Reading
-
Noosa News22 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Noosa News22 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush